| Mr Charles D Hanson, MD | |
|
52 Park St, Orono, ME 04473-4406 | |
| (207) 866-0408 | |
| (207) 989-5743 |
| Full Name | Mr Charles D Hanson |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 52 Park St, Orono, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679573257 | NPI | - | NPPES |
| 3165493 | Medicaid | MA |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Charles D Hanson, MD 52 Park St, Orono, ME 04473-4406 Ph: (207) 866-0408 | Mr Charles D Hanson, MD 52 Park St, Orono, ME 04473-4406 Ph: (207) 866-0408 |
News Archive
A Freiburg-based research group has developed a microfluidic chip where more than one hundred apidose-derived adult stem cell cultures can grow and divide. In the human body, adipose tissue acts as a primary energy store.
Allelica, a leading genomics software company specializing in developing polygenic risk scores (PRS) for personalised medicine, today announced publication of a study in Circulation (Vol. 143, Issue 10) showing that the effect of LDL cholesterol on a person's risk of having a heart attack depends on their genes.
Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow. These assets consist of key instrumentation in the comprehensive Roche NimbleGen microarray workflow including the NimbleGen Hybridization Systems (both 4- and 12-bay models).
Better-educated middle-aged Americans are less likely to smoke and more apt to be physically active than their less-educated peers. They are also more inclined to make healthy changes - in general and in the face of new medical conditions - and adhere to them, according to a new study in the September issue of the Journal of Health and Social Behavior.
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
› Verified 8 days ago
Dr. Lewis E Mehl-madrona, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 288 Main St, Orono, ME 04473 Phone: 808-772-1099 Fax: 207-406-5354 |